Literature DB >> 7621684

Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.

S Datey1, L N Gaur, B N Saxena.   

Abstract

Irregularity in vaginal bleeding patterns is the most common clinical side effect causing discontinuation of the method reported by the-users of the newer contraceptive methods, especially hormonal ones. An objective assessment of vaginal bleeding pattern is, therefore, critical in evaluation of a new contraceptive method for its acceptance and continued use. The menstrual diary records of women participating in clinical trials of several contraceptive methods undertaken by the Indian Council of Medical Research were analysed. It was observed that the long-acting progestogen-only hormonal contraceptives like levonorgestrel (LNG)-releasing subdermal implants Norplant or intrauterine devices (LNG-IUD) as well as injectable contraceptive NET-EN 200mg given 2 or 3 monthly produced disturbances in bleeding pattern in the majority of their users. Very heavy or prolonged bleeding, a potential health hazard was uncommon and a shift more towards infrequent bleeding was observed. In Norplant-II implants users, 75 to 80% of women had irregularities in bleeding pattern during the first year of use which improved with prolonged use. However, even at 4 years of use, about half of the users of Norplant-II implants continued to have irregular bleeding patterns. The bleeding disturbances occurred in 80% users of 200mg NET-EN injectable contraceptives also during first year of use, however unlike Norplant-II implants users, there was no improvement with prolonged use. Combined monthly injectable contraceptives containing 50mg NET-EN and 5mg estradiol valerate caused less bleeding problems with half of the users experiencing normal pattern during one year of its use. Combined low-dose oral pills, both triphasic and monophasic, produced much better cycle control as compared to any of the other hormonal contraceptive-treated groups; about 90% of combined oral pill users had normal bleeding patterns during one year of method use. The use of copper IUDs was associated with increased bleeding in 18 to 20% of women during the initial period of three months which improved with prolonged use. It was observed that the women having frequent or prolonged bleeding had discontinued the contraceptive method more often as compared to those having delayed bleeding episodes or oligomenorrhoea. However, discontinuation rates due to bleeding irregularities at one year were lower in Norplant-II implants users as compared to other long acting hormonal contraceptive methods such as injectables or IUDs in spite of similar or better bleeding patterns in women using these methods.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621684     DOI: 10.1016/0010-7824(95)00012-y

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

Review 1.  Triphasic versus monophasic oral contraceptives for contraception.

Authors:  Huib A A M Van Vliet; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Evidence-based guidance on Selected Practice Recommendations for Contraceptive Use: identification of research gaps.

Authors:  Suzanne G Folger; Denise J Jamieson; Emily M Godfrey; Lauren B Zapata; Kathryn M Curtis
Journal:  Contraception       Date:  2012-10-18       Impact factor: 3.375

3.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Current status of fertility control methods in India.

Authors:  R S Sharma; M Rajalakshmi; R S Sharma; D A Jeyaraj
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

Review 5.  Levonorgestrel subdermal implants. Contraception on trial.

Authors:  M L Frank; C DiMaria
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

Review 6.  Combination injectable contraceptives for contraception.

Authors:  Maria F Gallo; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Catherine d'Arcangues
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 7.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Comparing Women's Contraceptive Preferences With Their Choices in 5 Urban Family Planning Clinics in Ghana.

Authors:  Sarah D Rominski; Emmanuel Sk Morhe; Ernest Maya; Abukar Manu; Vanessa K Dalton
Journal:  Glob Health Sci Pract       Date:  2017-03-28

9.  Incidence and determinants of Implanon discontinuation: Findings from a prospective cohort study in three health zones in Kinshasa, DRC.

Authors:  P Z Akilimali; Hernandez J; Anglewicz P; Kayembe K P; Bertrand J
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

10.  Survival time to Implanon discontinuation and its predictors among a cohort of Implanon users who enrolled in public hospitals of southern Ethiopia, 2021: a retrospective cohort study.

Authors:  Aklilu Habte; Merertu Wondimu; Hanan Abdulkadir
Journal:  Arch Public Health       Date:  2022-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.